| Characteristics |
NO (%) |
| Age (years)
Range
Median |
26-74
55 |
| Sex
Male
Female |
29 (48.3)
31 (51.7) |
| Performance status (ECOG)
1
2 |
11 (18.3)
49 (91.7) |
| Primary tumor
Breast
Bladder
Multiple myeloma
Lung
Prostate
Others |
22 (36.7)
11 (18.3)
8 (13.3)
6 (10)
2 (3.4)
11 (18.3) |
| Metastatic site
Spines
Pelvis
Spines / Pelvis
Extremities |
33 (55)
15 (25)
7 (11.7)
5 (8.3) |
| Pain Score
2 (Moderate pain; 5-6 on pain scale)
3 (Severe pain; 7-10 on pain scale) |
29 (48.3)
31 (51.7) |
| Analgesic Score
1 (NSAI drugs)
2 (weak opoids)
3 (strong opoids) |
6 (10)
24 (40)
30 (50) |
| Dose and fractionation of first RTH
2000cGy / 5 fractions
3000 cGy / 10 fractions |
44 (73.3)
16 (26.7) |
| Interval between first RTH and re-irradiation
Range (months)
Median (months) |
6 – 54
18 |
| Re-irradiation Group
Group I ( single RTH dose of 8 Gys)
Group II (5 RTH doses; 4 Gys each) |
28 (46.7)
32 (53.3) |
| Total |
60 (100) |